Results 261 to 270 of about 188,968 (306)

Correction: Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma. [PDF]

PLoS One
Peng YL, Wang LX, Li MY, Liu LP, Li RS.
europepmc   +1 more source

Pan-Cell Death Protein Signature as a Novel Diagnostic and Prognostic Biomarker for Intracerebral Hemorrhage

Tianhong Wang, Wenbiao Huang, Zhe Li, ZhiWei Cao, Kuairong Pu, dongchuan shao, Jun Wu, Jin Li, Nan Zhao   +8 more
openalex   +1 more source

Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. [PDF]

Chin J Cancer Res
Xia W, Liu J, Chen R, Feng J, Wu L, Wang Y, Wang X, Song C, Mao W.   +8 more
europepmc   +1 more source

Constructing a prognostic signature of tumor-associated B lymphocytes in hepatocellular carcinoma via machine learning integration. [PDF]

Sci Rep
Zhang S, Qian J, Chen Y, Jin L.
europepmc   +1 more source

Multi-omics analysis of lactylation as a prognostic signature: A pan-cancer study. [PDF]

Genes Dis
Liu X, Wang Y, Cao Y, Zong J.
europepmc   +1 more source

Comment on: Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke—The 24‐h Time‐Point May be a Pro‐Thrombotic Blind Spot: Check 6‐h Fibrinogen Rebound to Catch Early Re‐Occluders

Annals of Clinical and Translational Neurology, EarlyView.
Qichao Fang, Luting Ying, Yongjin Gong
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prognostic immunologic signatures in epithelial ovarian cancer

Oncogene, 2022
Epithelial Ovarian Cancer (EOC) is a deadly gynecologic malignancy in which patients frequently develop recurrent disease following initial platinum-taxane chemotherapy. Analogous to many other cancer subtypes, EOC clinical trials have centered upon immunotherapeutic approaches, most notably programmed cell death 1 (PD-1) inhibitors.
Nicole E. James, Morgan Woodman, Jennifer R. Ribeiro   +2 more
openaire   +2 more sources

Diagnostic and Prognostic Sarcoma Signatures

Molecular Diagnosis & Therapy, 2008
Sarcomas are a diverse group of childhood and adult tumors that arise from mesenchymal tissue. In contrast to epithelial tumors, most of which are defined by a specific organ system, sarcomas can arise virtually anywhere in the body, such that their characteristic histopathology and clinical presentation form the core diagnostic criteria.Precise ...
Elai, Davicioni, Daniel H, Wai, Michael J, Anderson   +2 more
openaire   +2 more sources

Autophagy‐related prognostic signature for breast cancer

Molecular Carcinogenesis, 2015
Autophagy is a process that degrades intracellular constituents, such as long‐lived or damaged proteins and organelles, to buffer metabolic stress under starvation conditions. Deregulation of autophagy is involved in the progression of cancer. However, the predictive value of autophagy for breast cancer prognosis remains unclear.
Yunyan, Gu, Pengfei, Li, Fuduan, Peng, Mengmeng, Zhang, Yuanyuan, Zhang, Haihai, Liang, Wenyuan, Zhao, Lishuang, Qi, Hongwei, Wang, Chenguang, Wang, Zheng, Guo   +10 more
openaire   +2 more sources